Actinium 225 PSMA Radioligand Therapy for Prostate Cancer - 1 cycle | Vienna General Hospital, Austria
Vienna, Austria
Overview
Age group
Type of care
Method
About the offer
What’s included
Medical service
Examination
- clinical history-taking
- medical records review
- physical examination
- consultation with a nuclear medicine specialist
Laboratory tests
- complete blood count (CBC)
- biochemical analysis of blood (kidney and liver function tests, electrolytes)
- inflammation blood tests
- urinalysis
- PSA test
Diagnosis
- Ga-68 PSMA PET CT scan (on the indication, price is not included)
- renal scintigraphy with 99mTc-MAG3
Treatment
- pre-procedure patient preparation
- 1 session of Actinium-225 PSMA-617 radioligand therapy
- post-procedure care
- control examinations
- symptomatic treatment
Other
- cost of radiopharmaceuticals
- cost of essential medicines
- cost of essential materials
- doctors' fee
- hospitalization
- nursing service
- discharge medical records
- further recommendations
Distant service
- support after the therapy to evaluate the treatment results and subsequent blood tests
Extra add-ons
Local transportation
Airport transfer
Single room
Hospital meals
Personal coordinator
AiroCare
AiroMedical support
Payment protection
Patient advocacy
Price match
Meet the provider
Why to choose us?
Unique, specialized team
The Theranosticum Vienna, under the guidance of Univ.-Prof. Dr. Marcus Hacker, Univ.-Prof. Dr. Werner Langsteger, and Univ.-Prof. Mag. Markus Mitterhauser, specializes in nuclear medicine diagnostics and outpatient personalized therapies for various types of cancer. They are located at the Institute for Nuclear Medicine and Isotope Diagnostics at the Döbling Ambulatory and Vienna General Hospital for inpatient stay.
Personalized approach
The THERANOSTICS principle "we treat what we see" means that what was previously visible is treated. This principle enables a personalized therapy decision with radio ligand therapy, which is made exclusively in close coordination between the treating physician and the patient. Together, a suitable radiopharmaceutical is selected that binds selectively and with high precision to the surface of tumor cells, thus specifically destroying tumors and metastases while minimizing damage to the surrounding healthy tissue.
Life-changer for metastatic prostate cancer
The treatment can significantly increase the quality of life and extend the life span due to its good tolerability. Numerous studies have shown that it can produce good results, particularly in treating prostate cancer.
Gallery
Customize this offer
If you're not seeing exactly what you need here, send your custom request. You can discuss the content, specifics, price & timeline to create a personalized plan.
Location
Währinger Gürtel 18-20, 1090 Wien, Austria
FAQ
What is the cost?
The total price for Actinium 225 PSMA Radioligand Therapy for Prostate Cancer - 1 cycle | Vienna General Hospital, Austria is €39,965. However, it can vary from the specifics of each case. Get in touch to get an individual estimate.
What is the rating of the offer?
Actinium 225 PSMA Radioligand Therapy for Prostate Cancer - 1 cycle | Vienna General Hospital, Austria is rated as 9.80 by AiroMedical.
Who is offering a deal?
The provider is Univ. Prof. Dr. med. Marcus Hacker.
Individual cost estimate. Non-binding 100% free assessment.
HomeOffersActinium 225 PSMA Radioligand Therapy for Prostate Cancer - 1 cycle | Vienna General Hospital, Austria